Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11625-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11625-1-AP, RRID:AB_2260414
- Product name
- CDCA4 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated CDCA4 antibody (Cat. #11625-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ALKBH5 promotes the development of lung adenocarcinoma by regulating the polarization of M2 macrophages through CDCA4.
Construction of shared gene signature between rheumatoid arthritis and lung adenocarcinoma helps to predict the prognosis and tumor microenvironment of the LUAD patients.
CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway.
CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma.
CDCA4 suppresses epithelial-mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy.
Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin.
The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
Tan J, Chen F, Wang J, Li J, Ouyang B, Li X, Li Y, Zhang W, Jiang Y
Gene 2024 Feb 15;895:147975
Gene 2024 Feb 15;895:147975
Construction of shared gene signature between rheumatoid arthritis and lung adenocarcinoma helps to predict the prognosis and tumor microenvironment of the LUAD patients.
Shi L, Zou H, Yi J
Frontiers in molecular biosciences 2023;10:1314753
Frontiers in molecular biosciences 2023;10:1314753
CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway.
Feng S, Cao H, Sui Y, Shen Z, Wu J, Ma R, Feng J
Thoracic cancer 2023 Mar;14(8):724-735
Thoracic cancer 2023 Mar;14(8):724-735
CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma.
Tan J, Chen F, Ouyang B, Li X, Zhang W, Gao X
Frontiers in oncology 2022;12:865756
Frontiers in oncology 2022;12:865756
CDCA4 suppresses epithelial-mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy.
Xu C, Cao H, Sui Y, Zhang H, Shi C, Wu J, Ma R, Feng J
Cancer cell international 2021 Jan 12;21(1):48
Cancer cell international 2021 Jan 12;21(1):48
Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin.
Xia H, Cao J, Li Q, Lv Y, Jia W, Ren W, Cheng Q, Song X, Xu G
Scientific reports 2016 Oct 11;6:34856
Scientific reports 2016 Oct 11;6:34856
The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T, Ambesi-Impiombato A, Califano A, Migliazza A, Bhagat G, Dalla-Favera R
Cancer cell 2010 Jan 19;17(1):28-40
Cancer cell 2010 Jan 19;17(1):28-40
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CDCA4 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CDCA4. This antibody recognizes human antigen. The CDCA4 antibody has been validated for the following applications: ELISA, WB analysis.
